MEINI, GENNY
 Distribuzione geografica
Continente #
NA - Nord America 556
EU - Europa 116
AS - Asia 29
AF - Africa 7
SA - Sud America 3
Totale 711
Nazione #
US - Stati Uniti d'America 552
FR - Francia 35
IE - Irlanda 28
IT - Italia 19
VN - Vietnam 18
DE - Germania 13
CN - Cina 8
GB - Regno Unito 8
ZA - Sudafrica 6
CA - Canada 4
SE - Svezia 4
CL - Cile 2
CZ - Repubblica Ceca 2
IN - India 2
NL - Olanda 2
RU - Federazione Russa 2
BR - Brasile 1
BW - Botswana 1
ES - Italia 1
FI - Finlandia 1
GR - Grecia 1
SA - Arabia Saudita 1
Totale 711
Città #
Fairfield 79
Ashburn 51
Seattle 49
Buffalo 44
Woodbridge 36
Santa Cruz 34
Houston 27
Dublin 26
Cambridge 25
Wilmington 24
Dong Ket 18
Ann Arbor 17
Siena 15
Chicago 7
Las Vegas 6
Los Angeles 6
Muizenberg 6
Phoenix 6
Southend 6
Clearwater 5
New York 4
Ottawa 4
San Diego 4
Stockholm 4
University Park 4
Boardman 3
Council Bluffs 3
Paris 3
Shanghai 3
Bengaluru 2
Evington 2
Frankfurt Am Main 2
Henderson 2
Lake Forest 2
Milpitas 2
Oak Lawn 2
Riva 2
San Francisco 2
Sassari 2
Wuhan 2
Yellow Springs 2
Atlanta 1
Auburn 1
Bologna 1
Brockport 1
Cheyenne 1
Collado-villalba 1
Dallas 1
Falkenstein 1
Frankfurt am Main 1
Fremont 1
Gammertingen 1
Guangzhou 1
Helsinki 1
Mcallen 1
Munich 1
Neu-Ulm 1
Portland 1
Provo 1
Putian 1
Recife 1
Redwood City 1
San Jose 1
Verona 1
Totale 566
Nome #
Drug resistance testing through remote genotyping and predicted treatment options in human immunodeficiency virus type 1 infected Tanzanian subjects failing first or second line antiretroviral therapy, file e0feeaa6-467b-44d2-e053-6605fe0a8db0 140
Stability of unfrozen whole blood DNA for remote genotypic analysis of HIV-1 coreceptor tropism, file e0feeaa5-15a7-44d2-e053-6605fe0a8db0 132
Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-Week results of a randomized trial, file e0feeaa7-163b-44d2-e053-6605fe0a8db0 127
Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study group, file e0feeaa7-bee1-44d2-e053-6605fe0a8db0 126
Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy, file e0feeaa8-2314-44d2-e053-6605fe0a8db0 98
Switch to raltegravir-based regimens and HIV DNA decrease in patients with suppressed HIV RNA, file e0feeaa8-1398-44d2-e053-6605fe0a8db0 95
Frequent Detection of Antiretroviral Drug Resistance in HIV-1-Infected Orphaned Children Followed at a Donor-Funded Rural Pediatric Clinic in Dodoma, Tanzania, file e0feeaa5-fdce-44d2-e053-6605fe0a8db0 11
Changing patterns in HIV-1 non-B clade prevalence and diversity in Italy over three decades, file e0feeaa4-d8ec-44d2-e053-6605fe0a8db0 3
Dysfunctional phenotypes of CD4+ and CD8+ T cells are comparable in patients initiating ART during early or chronic HIV-1 infection, file e0feeaa6-da31-44d2-e053-6605fe0a8db0 3
Prevalence of HIV-1 integrase mutations related to resistance to dolutegravir in raltegravir naïve and pretreated patients., file e0feeaa4-f678-44d2-e053-6605fe0a8db0 2
Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA study group., file e0feeaa4-f679-44d2-e053-6605fe0a8db0 2
A Prognostic Model for Estimating the Time to Virologic Failure in HIV-1 Infected Patients Undergoing a New Combination Antiretroviral Therapy Regimen, file e0feeaa4-d6b6-44d2-e053-6605fe0a8db0 1
Total cellular HIV-1 DNA decreases after switching to raltegravir-based regimens in patients with suppressed HIV-1 RNA, file e0feeaa6-2906-44d2-e053-6605fe0a8db0 1
Development of an internally controlled quantitative PCR to measure total cell-associated HIV-1 DNA in blood, file e0feeaa7-1eef-44d2-e053-6605fe0a8db0 1
Totale 742
Categoria #
all - tutte 3.291
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.291


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201962 0 0 0 0 0 0 0 0 0 0 31 31
2019/2020202 20 17 16 25 16 20 14 22 22 9 6 15
2020/2021123 3 12 5 2 13 8 19 12 7 8 9 25
2021/2022130 5 19 3 0 18 7 7 6 3 4 45 13
2022/2023131 5 8 35 22 11 20 9 3 2 4 9 3
2023/202446 2 4 6 7 4 8 15 0 0 0 0 0
Totale 742